Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Relypsa Inc (NASDAQ:RLYP)

31.97
Delayed Data
As of Jul 25
 -0.10 / -0.31%
Today’s Change
10.26
Today|||52-Week Range
35.00
+12.81%
Year-to-Date
These 4 Stocks Could See Negative Catalysts From Earnings -- but What Do the Charts S...
Jul 22 / TheStreet.com - Paid Partner Content
Why Shares of Relypsa Are Soaring Today
Jul 21 / MotleyFool.com - Paid Partner Content
Synergy Pharma Offers Lots of Synergies
Jul 22 / TheStreet.com - Paid Partner Content
4 Small-Cap Biotechs With Big Stories to Tell
Jul 21 / TheStreet.com - Paid Partner Content
Synergy Pharma Offers Suitors Lots of Synergy
Jul 22 / TheStreet.com - Paid Partner Content
Relypsa Finally Finds Buyer, But Potential Seen For Rival Bid
Jul 21 / TheStreet.com - Paid Partner Content
Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Jul 21 / TheStreet.com - Paid Partner Content
Relypsa (RLYP) Stock Surging on $1.5 Billion Acquisition by Galencia
Jul 21 / TheStreet.com - Paid Partner Content
Investors Scour Big Pharma M&A Scene for Next Big Takeover
Jul 21 / TheStreet.com - Paid Partner Content
Morning Movers: GM, JOY, RLYP, BIIB
Jul 21 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close32.07
Today’s open31.92
Day’s range31.92 - 32.03
Volume6,096,736
Average volume (3 months)3,442,418
Market cap$1.4B
Dividend yield--
Data as of 07/25/2016

Growth & Valuation

Earnings growth (last year)-80.66%
Earnings growth (this year)-36.44%
Earnings growth (next 5 years)+21.09%
Revenue growth (last year)--
P/E ratioNM
Price/Sales62.18
Price/Book7.28

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd+0.25+1.77%
MCRBSeres Therapeutics I...-0.46-1.33%
FPRXFive Prime Therapeut...+0.54+1.14%
ARIAARIAD Pharmaceutical...+0.09+1.11%
Data as of 07/25/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$1.53
Annual revenue (last year)$18.6M
Annual profit (last year)-$178.7M
Net profit margin-963.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John A. Orwin
Chief Financial Officer &
Senior Vice President
Kristine McClintock Ball
Corporate headquarters
Redwood City, California

Forecasts

Partner Offers

Search for Jobs